30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

OrthoPediatrics Corp (KIDS)

Track

Over the last 90 days, OrthoPediatrics Corp. has seen significant insider selling, with a net value of -$1,003,449.75. Executives were the sole sellers during this period. The company's stock has experienced a 5.4% increase in the last 90 days, trading near the middle of its 52-week range. The last earnings report showed a 4.55% beat.
Stock chart
Ticker: KIDS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Hauser Joseph W
Pres. Trauma & Def. Correction
2 sales — total 296,600 USD
Sale 16 Mar 2026
Value US$1,149,724.91 | Price 29.56 | Shares 24,694
Proposed sale 16 Mar 2026
Value US$467,598.77 | Price 267.24 | Shares 76,369
Sale 16 Mar 2026
Value US$3,854,043.90 | Price 138.01 | Shares 77,026
Proposed sale 16 Mar 2026
Value US$1,014,025.46 | Price 196.38 | Shares 28,034
Sale 16 Mar 2026
Value US$145,469.25 | Price 17.25 | Shares 8,433
Proposed sale 16 Mar 2026
Value US$145,506.00 | Price 17.25 | Shares 8,433
Sale 16 Mar 2026
Value US$336,978.75 | Price 17.25 | Shares 19,535
Proposed sale 16 Mar 2026
Value US$337,065.00 | Price 17.25 | Shares 19,535
Sale 16 Mar 2026
Value US$148,591.50 | Price 17.25 | Shares 8,614
Proposed sale 16 Mar 2026
Value US$148,629.00 | Price 17.25 | Shares 8,614
Buy 21 Aug 2025
Value US$98,525.16 | Price 19.41 | Shares 5,076
Sale 18 Mar 2025
Value US$164,573.20 | Price 24.86 | Shares 6,620
Sale 18 Mar 2025
Value US$132,006.60 | Price 24.86 | Shares 5,310
Sale 18 Mar 2025
Value US$133,224.74 | Price 24.86 | Shares 5,359
Sale 18 Mar 2025
Value US$131,758.00 | Price 24.86 | Shares 5,300
Sale 18 Mar 2025
Value US$160,172.98 | Price 24.86 | Shares 6,443
Sale 21 Aug 2024
Value US$293,000.00 | Price 29.30 | Shares 10,000
Sale 11 Mar 2024
Value US$88,150.05 | Price 27.59 | Shares 3,195
Sale 11 Mar 2024
Value US$67,126.47 | Price 27.59 | Shares 2,433
Sale 11 Mar 2024
Value US$75,624.19 | Price 27.59 | Shares 2,741
Sale 11 Mar 2024
Value US$76,369.12 | Price 27.59 | Shares 2,768
Sale 11 Mar 2024
Value US$88,646.67 | Price 27.59 | Shares 3,213
Sale 22 Feb 2024
Value US$81,458.18 | Price 28.06 | Shares 2,903
Sale 11 Aug 2023
Value US$99,832.50 | Price 38.25 | Shares 2,610
Proposed sale 11 Aug 2023
Value US$99,237.77 | Price 38.02 | Shares 2,610
Proposed sale 26 Jun 2023
Value US$191,097.72 | Price 43.87 | Shares 4,356
Sale 26 Jun 2023
Value US$190,303.62 | Price 43.69 | Shares 4,356
Planned sale 27 Apr 2023
Value US$166,969.30 | Price 50.10 | Shares 3,333
Planned sale 25 Apr 2023
Value US$41,419.62 | Price 50.02 | Shares 828
Planned sale 21 Apr 2023
Value US$32,211.91 | Price 50.02 | Shares 644
Sale 6 Mar 2023
Value US$150,618.42 | Price 44.03 | Shares 3,421
Sale 6 Mar 2023
Value US$179,396.83 | Price 43.77 | Shares 4,099
Sale 6 Mar 2023
Value US$147,916.29 | Price 44.62 | Shares 3,315
Sale 6 Mar 2023
Value US$197,871.68 | Price 43.83 | Shares 4,515
Sale 6 Mar 2023
Value US$179,910.42 | Price 44.40 | Shares 4,052
Sale 2 Mar 2023
Value US$111,704.81 | Price 43.74 | Shares 2,554
Planned sale 2 Feb 2023
Value US$59,753.58 | Price 50.00 | Shares 1,195
Planned sale 20 Jan 2023
Value US$3,760.00 | Price 47.00 | Shares 80
Planned sale 13 Jan 2023
Value US$79,695.00 | Price 45.00 | Shares 1,771
Planned sale 9 Jan 2023
Value US$10,315.01 | Price 45.04 | Shares 229
Buy 16 Jun 2022
Value US$48,720.75 | Price 39.45 | Shares 1,235
Sale 2 Mar 2022
Value US$236,931.80 | Price 58.10 | Shares 4,078
Sale 2 Mar 2022
Value US$349,314.60 | Price 58.60 | Shares 5,961
Sale 2 Mar 2022
Value US$236,415.40 | Price 57.55 | Shares 4,108
Sale 2 Mar 2022
Value US$229,046.28 | Price 58.46 | Shares 3,918
Sale 2 Mar 2022
Value US$282,744.12 | Price 57.48 | Shares 4,919
Sale 7 Feb 2022
Value US$148,248.80 | Price 46.04 | Shares 3,220
Buy 10 Dec 2021
Value US$29,130.00 | Price 58.26 | Shares 500
Buy 9 Dec 2021
Value US$30,180.00 | Price 60.36 | Shares 500
Buy 9 Dec 2021
Value US$30,120.00 | Price 60.24 | Shares 500
Buy 9 Dec 2021
Value US$60,420.00 | Price 60.42 | Shares 1,000
Buy 11 Nov 2021
Value US$54,846.00 | Price 66.48 | Shares 825
Sale 7 Sep 2021
Value US$24,837.42 | Price 69.19 | Shares 359
Planned sale 2 Aug 2021
Value US$133,200.00 | Price 66.60 | Shares 2,000
Sale 15 Jun 2021
Value US$19,362.00 | Price 64.54 | Shares 300
Buy 13 May 2021
Value US$28,070.00 | Price 56.14 | Shares 500
Buy 13 May 2021
Value US$28,065.00 | Price 56.13 | Shares 500
Buy 13 May 2021
Value US$27,945.00 | Price 55.89 | Shares 500
Buy 13 May 2021
Value US$86,235.00 | Price 57.49 | Shares 1,500
Sale 10 May 2021
Value US$252,120.00 | Price 63.03 | Shares 4,000
Planned sale 6 May 2021
Value US$192,540.00 | Price 60.00 | Shares 3,209
Planned sale 3 May 2021
Value US$225,750.00 | Price 60.20 | Shares 3,750
Planned sale 3 May 2021
Value US$288,178.65 | Price 60.15 | Shares 4,791
Sale 16 Mar 2021
Value US$32,046.00 | Price 45.78 | Shares 700
Buy 15 Mar 2021
Value US$172,050.00 | Price 46.50 | Shares 3,700
Buy 15 Mar 2021
Value US$135,302.40 | Price 46.98 | Shares 2,880
Sale 1 Mar 2021
Value US$147,053.05 | Price 55.85 | Shares 2,633
Sale 1 Mar 2021
Value US$240,799.70 | Price 55.87 | Shares 4,310
Sale 1 Mar 2021
Value US$457,824.84 | Price 55.88 | Shares 8,193
Sale 1 Mar 2021
Value US$266,300.96 | Price 55.84 | Shares 4,769
Sale 1 Mar 2021
Value US$284,820.36 | Price 55.88 | Shares 5,097
Planned sale 25 Feb 2021
Value US$39,843.00 | Price 57.00 | Shares 699
Planned sale 22 Feb 2021
Value US$91,344.00 | Price 57.09 | Shares 1,600
Planned sale 19 Feb 2021
Value US$97,229.16 | Price 57.16 | Shares 1,701
Planned sale 19 Feb 2021
Value US$211,875.00 | Price 56.50 | Shares 3,750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-17 2026-03-16 S Sale
3.0
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
24,694 +44.3%
29.56
US$1,149,725 		24,694 +44.3% 29.56 US$1,149,725
2026-03-17 2026-03-16 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
77,026 +9.5%
138.01
US$3,854,044 		77,026 +9.5% 138.01 US$3,854,044
2026-03-17 2026-03-16 S Sale
3.2
Odle Gregory A

President of Scoliosis

Officer
87,036 -39.9%
412.06
US$1,797,581 		87,036 -39.9% 412.06 US$1,797,581
2026-03-17 2026-03-16 S Sale
2.6
Bailey David R

President and CEO

Executive Director
19,535 -6.2%
17.25
US$336,979 		19,535 -6.2% 17.25 US$336,979
2026-03-17 2026-03-16 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
8,614 -5.4%
17.25
US$148,592 		8,614 -5.4% 17.25 US$148,592
2026-03-16 2026-03-16 PrS Proposed sale
3.2
Odle Gregory A

Officer

Officer
8,433
17.25
US$145,506 		8,433 17.25 US$145,506
2026-03-16 2026-03-16 PrS Proposed sale
2.2
Hite Fred

Officer

Officer
12,993
17.25
US$224,186 		12,993 17.25 US$224,186
2026-03-16 2026-03-16 PrS Proposed sale
3.0
Hauser Joseph W

Officer

Officer
8,596
17.25
US$148,319 		8,596 17.25 US$148,319
2026-03-16 2026-03-16 PrS Proposed sale
3.4
Gerritzen Daniel J

Officer

Officer
8,614
17.25
US$148,629 		8,614 17.25 US$148,629
2026-03-16 2026-03-16 PrS Proposed sale
2.6
Bailey David R

Officer

Officer
19,535
17.25
US$337,065 		19,535 17.25 US$337,065
2025-08-25 2025-08-21 B Purchase
2.2
Hite Fred

COO and CFO

Executive Director
5,076 +2.4%
19.41
US$98,525 		5,076 +2.4% 19.41 US$98,525
2025-03-18 2025-03-18 S Sale
2.6
Bailey David R

President and CEO

Executive Director
6,620 -2.0%
24.86
US$164,573 		6,620 -2.0% 24.86 US$164,573
2025-03-18 2025-03-18 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
5,310 -4.6%
24.86
US$132,007 		5,310 -4.6% 24.86 US$132,007
2025-03-18 2025-03-18 S Sale
3.2
Odle Gregory A

President of Scoliosis

Officer
5,359 -3.5%
24.86
US$133,225 		5,359 -3.5% 24.86 US$133,225
2025-03-18 2025-03-18 S Sale
3.0
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
5,300 -3.7%
24.86
US$131,758 		5,300 -3.7% 24.86 US$131,758
2025-03-18 2025-03-18 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
6,443 -3.0%
24.86
US$160,173 		6,443 -3.0% 24.86 US$160,173
2024-08-22 2024-08-21 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
10,000 -11.5%
29.30
US$293,000 		10,000 -11.5% 29.30 US$293,000
2024-03-12 2024-03-11 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
3,195 -3.3%
27.59
US$88,150 		3,195 -3.3% 27.59 US$88,150
2024-03-12 2024-03-11 S Sale
2.5
Throdahl Mark C
Non-Executive Director
2,433 -1.7%
27.59
US$67,126 		2,433 -1.7% 27.59 US$67,126
2024-03-12 2024-03-11 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
2,741 -5.0%
27.59
US$75,624 		2,741 -5.0% 27.59 US$75,624
2024-03-12 2024-03-11 S Sale
3.2
Odle Gregory A

President of Scoliosis

Officer
2,768 -3.3%
27.59
US$76,369 		2,768 -3.3% 27.59 US$76,369
2024-03-12 2024-03-11 S Sale
2.6
Bailey David R

President and CEO

Executive Director
3,213 -2.3%
27.59
US$88,647 		3,213 -2.3% 27.59 US$88,647
2024-02-23 2024-02-22 S Sale
3.0
Hauser Joseph W

Pres. Trauma & Def. Correction

Officer
2,903 -5.2%
28.06
US$81,458 		2,903 -5.2% 28.06 US$81,458
2023-08-14 2023-08-11 S Sale
3.0
Schlotterback Terry D
Non-Executive Director
2,610 -14.5%
38.25
US$99,832 		2,610 -14.5% 38.25 US$99,832
2023-08-11 2023-08-11 PrS Proposed sale
3.0
Schlotterback Terry D

Director

Non-Executive Director
2,610
38.02
US$99,238 		2,610 38.02 US$99,238
2023-06-26 2023-06-26 PrS Proposed sale
2.2
Hite Fred

Officer; Director, CFO & COO

Executive Director
4,356
43.87
US$191,098 		4,356 43.87 US$191,098
2023-06-26 2023-06-26 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,356 -4.3%
43.69
US$190,304 		4,356 -4.3% 43.69 US$190,304
2023-04-28 2023-04-27 PlS Planned sale
3.2
Odle Gregory A

President of Scoliosis

Officer
3,333 -3.8%
50.10
US$166,969 		3,333 -3.8% 50.10 US$166,969
2023-04-26 2023-04-25 PlS Planned sale
3.2
Odle Gregory A

President of Scoliosis

Officer
828 -0.9%
50.02
US$41,420 		828 -0.9% 50.02 US$41,420
2023-04-24 2023-04-21 PlS Planned sale
3.2
Odle Gregory A

President of Scoliosis

Officer
644 -0.7%
50.02
US$32,212 		644 -0.7% 50.02 US$32,212
2023-03-07 2023-03-06 S Sale
3.2
Odle Gregory A

Executive Vice President

Officer
3,421 -4.8%
44.03
US$150,618 		3,421 -4.8% 44.03 US$150,618
2023-03-07 2023-03-06 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,099 -5.4%
43.77
US$179,397 		4,099 -5.4% 43.77 US$179,397
2023-03-07 2023-03-06 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
3,315 -8.5%
44.62
US$147,916 		3,315 -8.5% 44.62 US$147,916
2023-03-07 2023-03-06 S Sale
2.5
Throdahl Mark C
Non-Executive Director
4,515 -3.4%
43.83
US$197,872 		4,515 -3.4% 43.83 US$197,872
2023-03-07 2023-03-06 S Sale
2.6
Bailey David R

President and CEO

Executive Director
4,052 -3.9%
44.40
US$179,910 		4,052 -3.9% 44.40 US$179,910
2023-03-06 2023-03-02 S Sale
3.0
Hauser Joseph W

Sr VP & GM Trauma & Deformity

Officer
2,554 -6.6%
43.74
US$111,705 		2,554 -6.6% 43.74 US$111,705
2023-02-03 2023-02-02 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
1,195 -1.6%
50.00
US$59,754 		1,195 -1.6% 50.00 US$59,754
2023-01-24 2023-01-20 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
80 -0.1%
47.00
US$3,760 		80 -0.1% 47.00 US$3,760
2023-01-17 2023-01-13 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
1,771 -2.4%
45.00
US$79,695 		1,771 -2.4% 45.00 US$79,695
2023-01-10 2023-01-09 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
229 -0.3%
45.04
US$10,315 		229 -0.3% 45.04 US$10,315
2022-06-16 2022-06-16 B Purchase
3.6
Ruf Harold
Non-Executive Director
1,235 +9.8%
39.45
US$48,721 		1,235 +9.8% 39.45 US$48,721
2022-03-03 2022-03-02 S Sale
2.6
Bailey David R

President and CEO

Executive Director
4,078 -4.3%
58.10
US$236,932 		4,078 -4.3% 58.10 US$236,932
2022-03-03 2022-03-02 S Sale
2.5
Throdahl Mark C
Non-Executive Director
5,961 -4.6%
58.60
US$349,315 		5,961 -4.6% 58.60 US$349,315
2022-03-03 2022-03-02 S Sale
3.2
Odle Gregory A

Executive Vice President

Officer
4,108 -6.1%
57.55
US$236,415 		4,108 -6.1% 57.55 US$236,415
2022-03-03 2022-03-02 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
3,918 -12.7%
58.46
US$229,046 		3,918 -12.7% 58.46 US$229,046
2022-03-03 2022-03-02 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,919 -7.5%
57.48
US$282,744 		4,919 -7.5% 57.48 US$282,744
2022-03-03 2022-02-07 S Sale
3.0
Hauser Joseph W

Sr VP & GM Trauma & Deformity

Officer
3,220 -10.8%
46.04
US$148,249 		3,220 -10.8% 46.04 US$148,249
2021-12-13 2021-12-10 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +241.5%
58.26
US$29,130 		500 +241.5% 58.26 US$29,130
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +62.5%
60.36
US$30,180 		500 +62.5% 60.36 US$30,180
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +62.5%
60.24
US$30,120 		500 +62.5% 60.24 US$30,120
2021-12-13 2021-12-09 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
1,000 +10.1%
60.42
US$60,420 		1,000 +10.1% 60.42 US$60,420
2021-11-12 2021-11-11 B Purchase
3.2
Pelizzon David R
Non-Executive Director
825 +3.7%
66.48
US$54,846 		825 +3.7% 66.48 US$54,846
2021-09-13 2021-09-07 S Sale
1.8
Infante (Reynolds) Marie C
Non-Executive Director
359 -6.8%
69.19
US$24,837 		359 -6.8% 69.19 US$24,837
2021-08-03 2021-08-02 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
2,000 -7.8%
66.60
US$133,200 		2,000 -7.8% 66.60 US$133,200
2021-06-16 2021-06-15 S Sale
2.8
Berry Bernie B III
Non-Executive Director
300 -1.2%
64.54
US$19,362 		300 -1.2% 64.54 US$19,362
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
56.14
US$28,070 		500 +inf% 56.14 US$28,070
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
56.13
US$28,065 		500 +inf% 56.13 US$28,065
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
500 +inf%
55.89
US$27,945 		500 +inf% 55.89 US$27,945
2021-05-17 2021-05-13 B Purchase
3.3
Pritzker Jennifer N.
Large shareholder
1,500 +18.8%
57.49
US$86,235 		1,500 +18.8% 57.49 US$86,235
2021-05-12 2021-05-10 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
4,000 -11.5%
63.03
US$252,120 		4,000 -11.5% 63.03 US$252,120
2021-05-06 2021-05-06 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
3,209 -11.6%
60.00
US$192,540 		3,209 -11.6% 60.00 US$192,540
2021-05-04 2021-05-03 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
3,750 -5.3%
60.20
US$225,750 		3,750 -5.3% 60.20 US$225,750
2021-05-04 2021-05-03 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
4,791 -14.8%
60.15
US$288,179 		4,791 -14.8% 60.15 US$288,179
2021-03-17 2021-03-16 S Sale
1.8
Infante (Reynolds) Marie C
Non-Executive Director
700 -15.2%
45.78
US$32,046 		700 -15.2% 45.78 US$32,046
2021-03-17 2021-03-15 B Purchase
3.2
Pelizzon David R
Non-Executive Director
3,700 +21.5%
46.50
US$172,050 		3,700 +21.5% 46.50 US$172,050
2021-03-17 2021-03-15 B Purchase
3.6
Ruf Harold
Non-Executive Director
2,880 +18.3%
46.98
US$135,302 		2,880 +18.3% 46.98 US$135,302
2021-03-03 2021-03-01 S Sale
3.4
Gerritzen Daniel J

General Counsel and Secretary

Officer
2,633 -8.3%
55.85
US$147,053 		2,633 -8.3% 55.85 US$147,053
2021-03-03 2021-03-01 S Sale
2.2
Hite Fred

COO and CFO

Executive Director
4,310 -6.3%
55.87
US$240,800 		4,310 -6.3% 55.87 US$240,800
2021-03-03 2021-03-01 S Sale
3.2
Odle Gregory A

Executive Vice President

Officer
8,193 -11.3%
55.88
US$457,825 		8,193 -11.3% 55.88 US$457,825
2021-03-03 2021-03-01 S Sale
2.6
Bailey David R

President

Officer
4,769 -5.1%
55.84
US$266,301 		4,769 -5.1% 55.84 US$266,301
2021-03-03 2021-03-01 S Sale
2.5
Throdahl Mark C

CEO

Executive Director
5,097 -3.4%
55.88
US$284,820 		5,097 -3.4% 55.88 US$284,820
2021-03-01 2021-02-25 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
699 -2.1%
57.00
US$39,843 		699 -2.1% 57.00 US$39,843
2021-02-23 2021-02-22 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
1,600 -4.6%
57.09
US$91,344 		1,600 -4.6% 57.09 US$91,344
2021-02-22 2021-02-19 PlS Planned sale
2.8
Berry Bernie B III
Non-Executive Director
1,701 -4.7%
57.16
US$97,229 		1,701 -4.7% 57.16 US$97,229
2021-02-22 2021-02-19 PlS Planned sale
3.2
Odle Gregory A

Executive Vice President

Officer
3,750 -4.9%
56.50
US$211,875 		3,750 -4.9% 56.50 US$211,875
Explore more

More insider trading research around OrthoPediatrics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America